Background Gabapentin is commonly used to treat neuropathic pain (pain due to nerve
damage). This review updates a review published in 2014, and previous reviews published …

Background and objectives: This second European Federation of Neurological Societies
Task Force aimed at updating the existing evidence about the pharmacological treatment of …

The Neuropathic Pain Special Interest Group of the International Association for the Study of
Pain recently sponsored the development of evidence-based guidelines for the …

Randomized, double-blind, placebo-controlled trials on neuropathic pain treatment are
accumulating, so an updated review of the available evidence is needed. Studies were …

Background This review is an update of a review published in 2011, itself a major update of
previous reviews published in 2005 and 2000, investigating the effects of gabapentin in …

Gabapentin is an anti-epileptic agent but now it is also recommended as first line agent in
neuropathic pain, particularly in diabetic neuropathy and post herpetic neuralgia. α2δ-1, an …

Background Drugs for neuropathic pain have incomplete efficacy and dose-limiting side-
effects when given as monotherapy. We assessed the efficacy and tolerability of combined …

Background Chronic pain is common in adults, and often has a detrimental impact upon
physical ability, well‐being, and quality of life. Previous reviews have shown that certain …

Gabapentin and pregabalin for chronic neuropathic and early... : Current Opinion in
Anesthesiology Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain …

Background Antidepressants are widely used to treat chronic neuropathic pain (pain due to
nerve damage), usually in doses below those at which they exert antidepressant effects. An …